Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial
Aditya H. Gaur(St. Jude Children's Research Hospital), R. Kiplin Guy(St. Jude Children's Research Hospital), John Woodford(National Institute of Allergy and Infectious Diseases), Amber M. Smith(University of Tennessee Health Science Center), Nehali Patel(St. Jude Children's Research Hospital), Ronald H. Dallas(St. Jude Children's Research Hospital), John C. Panetta(St. Jude Children's Research Hospital), Tracy B. Stewart, Ryan N. Heine(St. Jude Children's Research Hospital), Burgess B. Freeman(St. Jude Children's Research Hospital), James McCarthy(Walter and Eliza Hall Institute of Medical Research), Lidiya Bebrevska(Medicines for Malaria Venture), Kristen Branum(St. Jude Children's Research Hospital), Yvonne Van Gessel(Eisai (United States)), Shelley Ost(University of Tennessee Health Science Center), Branko Mitasev(Eisai (United States)), Li Tang(St. Jude Children's Research Hospital), Robbin Christensen(St. Jude Children's Research Hospital), Fabian Gusovsky(Eisai (Japan)), Julie Richardson(St. Jude Children's Research Hospital), Elizabeth John, Patricia M. Flynn(St. Jude Children's Research Hospital), Jörg J. Möhrle(Medicines for Malaria Venture), Stephan Chalon(Medicines for Malaria Venture)
Cited by 77
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
|PLoS Pathogens|2009|808
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580